Table 1 Characteristics and outcomes of patients categorized by GPR.

From: The U shape relationship between glucose and potassium ratio and mortality in patients with subarachnoid hemorrhage in the US population

 

Overall (n = 855)

Q1 (n = 214)

Q2 (n = 214)

Q3 (n = 213)

Q4 (n = 214)

P-value

GPR

1.90 (1.59, 2.28)

1.41 (1.30, 1.49)

1.75 (1.69, 1.81)

2.06 (1.97, 2.15)

2.67 (2.45, 3.00)

 < 0.001

Demographic

 Age (y, IQR)

61.31 (51.12, 73.42)

61.11 (50.92, 76.69)

58.44 (49.35, 70.35)

61.92 (51.83, 74.12)

63.07 (54.30, 75.38)

0.037

 Male (n, %)

377 (44.1)

107 (50.0)

103 (48.1)

85 (39.9)

82 (38.3)

0.031

Clinical severity

 

 GCS

14.00 (13.00, 15.00)

14.00 (14.00, 15.00)

14.00 (13.00, 15.00)

14.00 (10.00, 15.00)

14.00 (11.00, 15.00)

0.029

 SOFA

2.00 (1.00, 4.00)

2.00 (1.00, 3.75)

2.00 (1.00, 4.00)

2.00 (1.00, 4.00)

3.00 (2.00, 6.00)

 < 0.001

 SAPSII

29.00 (23.00, 39.00)

27.00 (22.00, 36.75)

28.00 (22.00, 36.00)

30.00 (23.00, 38.00)

35.00 (26.25, 44.00)

 < 0.001

 OASIS

29.00 (24.00, 36.00)

26.50 (22.00, 32.00)

28.00 (23.00, 33.75)

30.00 (25.00, 37.00)

33.00 (27.25, 40.00)

 < 0.001

 SIRS

2.00 (2.00, 3.00)

2.00 (1.00, 3.00)

2.00 (2.00, 3.00)

3.00 (2.00, 3.00)

3.00 (2.00, 4.00)

 < 0.001

Vital signs

 Heart rate (beats/min)

76.82 (69.53, 86.50)

72.89 (67.19, 82.09)

76.81 (69.20, 84.10)

77.00 (69.93, 85.54)

81.19 (71.62, 90.64)

 < 0.001

 SBP (mmHg)

125.72 (116.46, 133.61)

121.12 (112.43, 129.13)

126.31 (117.00, 133.24)

126.90 (118.68, 134.77)

128.21 (117.63, 134.28)

 < 0.001

 DBP (mmHg)

63.62 (57.94, 69.89)

64.01 (58.57, 71.07)

64.54 (58.43, 71.31)

63.22 (57.73, 68.64)

62.46 (57.29, 68.99)

0.057

 MBP (mmHg)

82.07 (75.87, 87.94)

80.54 (74.12, 87.75)

83.46 (76.47, 89.75)

82.04 (76.48, 87.87)

82.53 (76.86, 87.66)

0.038

 Respiratory rates (breath/min)

17.65 (15.94, 19.56)

17.00 (15.30, 18.81)

16.91 (15.65, 18.64)

17.84 (16.17, 19.88)

18.92 (16.73, 21.09)

 < 0.001

 Temperature (℃)

36.98 (36.75, 37.27)

36.92 (36.73, 37.12)

36.98 (36.78, 37.27)

37.05 (36.79, 37.32)

37.05 (36.73, 37.31)

0.009

 SPO2

97.60 (96.07, 98.90)

97.22 (96.00, 98.23)

97.64 (96.14, 98.96)

97.59 (96.24, 99.08)

98.08 (96.15, 99.28)

 < 0.001

Laboratory parameters

 Hb (g/dL)

12.40 (11.16, 13.60)

12.28 (10.95, 13.60)

12.60 (11.35, 13.70)

12.47 (11.40, 13.40)

12.35 (11.10, 13.59)

0.433

 RBC (109/L)

4.08 (3.66, 4.48)

4.04 (3.62, 4.52)

4.10 (3.68, 4.50)

4.06 (3.69, 4.44)

4.09 (3.63, 4.47)

0.805

 WBC (109/L)

11.40 (8.90, 14.57)

9.32 (7.40, 11.72)

10.97 (8.75, 13.19)

12.70 (9.75, 15.15)

13.81 (10.81, 17.32)

 < 0.001

 PLT (109/L)

214.67 (174.38, 262.17)

204.75 (169.00, 246.62)

215.50 (179.71, 260.12)

223.00 (179.00, 275.00)

214.83 (167.17, 262.33)

0.038

 Sodium (mmol/L)

139.50 (137.50, 141.50)

139.50 (137.12, 141.46)

140.00 (138.00, 141.94)

139.00 (137.00, 141.00)

139.58 (137.67, 142.00)

0.031

 Glucose (mmol/L)

7.33 (6.32, 8.69)

5.78 (5.36, 6.28)

6.87 (6.44, 7.35)

7.83 (7.33, 8.39)

10.30 (9.00, 12.03)

 < 0.001

 Potassium (mmol/L)

3.90 (3.65, 4.20)

4.15 (3.90, 4.45)

3.90 (3.71, 4.16)

3.80 (3.60, 4.10)

3.80 (3.55, 4.10)

 < 0.001

Comorbidities

 Myocardial infarct (n, %)

70 (8.2)

14 (6.5)

8 (3.7)

24 (11.3)

24 (11.2)

0.008

 Heart failure (n, %)

73 (8.5)

26 (12.1)

12 (5.6)

16 (7.5)

19 (8.9)

0.1

 Peripheral vascular disease (n, %)

63 (7.4)

18 (8.4)

14 (6.5)

15 (7.0)

16 (7.5)

0.898

 Chronic pulmonary disease (n, %)

125 (14.6)

32 (15.0)

28 (13.1)

32 (15.0)

33 (15.4)

0.905

 Rheumatic disease

14 (1.6)

4 (1.9)

4 (1.9)

1 (0.5)

5 (2.3)

0.458

 Hepatic disorders (n, %)

40 (4.7)

11 (5.1)

11 (5.1)

8 (3.8)

10 (4.7)

0.894

 Diabetes mellitus (n, %)

119 (13.9)

17 (7.9)

9 (4.2)

20 (9.4)

73 (34.1)

 < 0.001

 Renal disease

63 (7.4)

18 (8.4)

9 (4.2)

15 (7.0)

21 (9.8)

0.146

 Malignant neoplasms (n, %)

43 (5.0)

12 (5.6)

8 (3.7)

12 (5.6)

11 (5.1)

0.786

 CCI

4.00 (2.00, 6.00)

4.00 (2.00, 5.00)

3.00 (2.00, 5.00)

4.00 (2.00, 6.00)

4.00 (3.00, 6.00)

 < 0.001

 Sepsis

404 (47.3)

61 (28.5)

93 (43.5)

103 (48.4)

147 (68.7)

 < 0.001

 Mechanical ventilation (n, %)

409 (47.8)

56 (26.2)

99 (46.3)

107 (50.2)

147 (68.7)

 < 0.001

Outcomes

 30-day ACM (n, %)

158 (18.5)

31 (14.5)

30 (14.0)

34 (16.0)

63 (29.4)

 < 0.001

 90-day ACM (n, %)

194 (22.7)

43 (20.1)

40 (18.7)

40 (18.8)

71 (33.2)

 < 0.001

 1-year ACM (n, %)

226 (26.4)

51 (23.8)

45 (21.0)

49 (23.0)

81 (37.9)

 < 0.001